← FDA DRUG APPROVALS

FDA ANDA · ANDA074806

PERMETHRIN

Sponsor: ACTAVIS LABS

APPLICATION
ANDA074806
TYPE
ANDA
ORIGINAL APPROVAL
1998-01-23
LATEST ACTION
2002-12-19
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

PERMETHRINPrescription
PERMETHRIN 5% · CREAM · TOPICAL

Approval history

2002-12-19Labeling · Supplement 14AP
2002-04-10Manufacturing (CMC) · Supplement 12AP
2002-04-10Manufacturing (CMC) · Supplement 13AP
2001-09-04Manufacturing (CMC) · Supplement 10AP
2001-09-04Manufacturing (CMC) · Supplement 9AP
2001-09-04Manufacturing (CMC) · Supplement 11AP
2001-01-08Manufacturing (CMC) · Supplement 8AP
2001-01-08Manufacturing (CMC) · Supplement 6AP
2000-12-29Manufacturing (CMC) · Supplement 7AP
2000-11-30Manufacturing (CMC) · Supplement 5AP
2000-09-21Labeling · Supplement 4AP
2000-09-21Manufacturing (CMC) · Supplement 3AP
1999-09-24Labeling · Supplement 1AP
1999-06-08Manufacturing (CMC) · Supplement 2AP
1998-01-23OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →